Pharmacia & Upjohn Company Inc. | Pfizer | kickbacks and bribery | 2007 | USAO | $19,700,000 |
Pharmacia & Upjohn Company LLC | Pfizer | kickbacks and bribery | 2007 | USAO | $15,000,000 |
AbbVie Inc. | AbbVie | kickbacks and bribery | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000 |
Alere Inc. | Abbott Laboratories | kickbacks and bribery | 2017 | MS-AG | $2,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
Mallinckrodt ARD LLC | Mallinckrodt | kickbacks and bribery | 2019 | DOJ_CIVIL | $15,400,000 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
Pfizer, Inc. | Pfizer | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Sanofi US Services, Inc. | Sanofi | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
Schering-Plough Corporation | Merck | kickbacks and bribery | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | KY-AG | $600,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | WI-AG | $798,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
Novartis Pharmaceuticals Corp. | Novartis | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Schering-Plough Corporation | Merck | investor protection violation | 2003 | SEC | $1,000,000 |
Allergan Inc. | AbbVie | investor protection violation | 2017 | SEC | $15,000,000 |
Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
Cytrx Corporation | CytRx | investor protection violation | 2017 | SEC | $75,000 |
Clovis Oncology Inc. | Clovis Oncology | investor protection violation | 2018 | SEC | $20,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
Mylan N.V. | Viatris | investor protection violation | 2019 | SEC | $30,000,000 |
Amyris, Inc. | Amyris | investor protection violation | 2021 | SEC | $300,000 |
Valeant Pharmaceuticals, Inc. | Bausch Health | insurance violation | 2018 | CA-INS | $1,875,000 |
Johnson & Johnson, Inc. | Johnson & Johnson | insurance violation | 2020 | NC-INS | $150,000 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | HHS civil monetary penalties | 2007 | HHSOIG | $2,950,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
Dey, Inc. | Viatris | fraud | 2004 | AR-AG | $600,000 |
Purdue Pharma LP | Purdue Pharma | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
Micrus Corporation | Johnson & Johnson | Foreign Corrupt Practices Act | 2005 | DOJ_CRIMINAL | $450,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Schering-Plough Corporation | Merck | Foreign Corrupt Practices Act | 2004 | SEC | $500,000 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Sanofi | Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
Novartis Hellas S.A.C.I. et al. | Novartis | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
InterMune Inc. | Roche | Family and Medical Leave Act | 2014 | WHD | $59,085 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Schering Corporation | Merck | Family and Medical Leave Act | 2006 | WHD | $6,000 |
ExecuPharm, Inc. | Parexel International | Family and Medical Leave Act | 2017 | WHD | $5,900 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | DOJ_CIVIL | $39,000,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2013 | DOJ_CIVIL | $5,475,000 |
Sanofi-Aventis U.S. Inc. | Sanofi | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
Acclarent Inc. | Johnson & Johnson | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Serono Laboratories Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | DOJ_CIVIL | $44,300,000 |
Dey Inc. | Viatris | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2010 | DOJ_CIVIL | $3,725,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Merck & Company | Merck | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2004 | DOJ_CIVIL | $27,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
Pfizer Corporation | Pfizer | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Forest Laboratories and Forest Pharmaceuticals | AbbVie | False Claims Act and related | 2016 | DOJ_CIVIL | $38,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |